ONVO 1 (-2.91%)
US68620A2033Medical Diagnostics & ResearchDiagnostics & Research

Organovo Holdings (ONVO) Competitor Comparison

We are evaluating the key criteria listed to compare Organovo Holdings (ONVO) against its competitors in the Diagnostics & Research industry.

Earnings per Share - ONVO ranking 46 / 57

These are the competitors of Organovo Holdings in the industry Diagnostics & Research ranked by earnings per share
1. Mettler-Toledo MTD
35.9
2. Thermo Fisher Scientific TMO
15.43
3. Waters WAT
10.83
4. IDEXX Laboratories IDXX
10.08
5. Charles River Laboratories CRL
9.22
6. Medpace Holdings MEDP
8.87
7. Quest Diagnostics DGX
7.49
8. Icon ICLR
7.41
9. IQVIA Holdings IQV
7.29
10. Danaher DHR
5.65
11. Lantheus Holdings LNTH
4.65
12. Prenetics Global PRE
4.35
13. Laboratory Corp of America Holdings LH
4.33
14. Agilent Technologies A
4.19
15. PerkinElmer PKI
2.78
16. Qiagen QGEN
1.53
17. DexCom DXCM
1.3
18. National Research NRC
1.25
19. Syneos Health SYNH
0.7
20. Global Cord Blood CO
0.59
21. Interpace Biosciences IDXG
0.25
22. Sotera Health SHC
0.18
23. RadNet RDNT
0.05
24. Neogen NEOG
0.02
25. Ortho Clinical Diagnostics Holdings OCDX
0
26. Olink Holding OLK
-0.25
27. Anixa Biosciences ANIX
-0.34
28. MaxCyte MXCT
-0.37
29. Enzo Biochem ENZ
-0.47
30. Biodesix BDSX
-0.64
31. NeoGenomics NEO
-0.7
32. Psychemedics PMD
-0.72
33. bioAffinity Technologies BIAF
-0.91
34. Neuronetics STIM
-1.05
35. Exact Sciences EXAS
-1.13
36. Sera Prognostics SERA
-1.16
37. Co-Diagnostics CODX
-1.2
38. Pacific Biosciences of California PACB
-1.21
39. Inotiv NOTV
-1.29
40. Exagen XGN
-1.34
41. Bioventus BVS
-1.54
42. Aspira Womens Health AWH
-1.81
43. Heska HSKA
-1.92
44. DarioHealth DRIO
-1.93
45. MDxHealth MDXH
-2.1
46. Organovo Holdings ONVO
-2.16
47. Personalis PSNL
-2.25
48. Myriad Genetics MYGN
-3.18
49. CareDx CDNA
-3.54
50. Twist Bioscience TWST
-3.61
51. Natera NTRA
-3.78
52. Guardant Health GH
-4.28
53. Precipio PRPO
-4.51
54. Trinity Biotech TRIB
-4.96
55. Fulgent Genetics FLGT
-5.63
56. Illumina ILMN
-7.34
57. SeqLL SQL
-16.4

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.